DIVITUM
Live / Registered — Registered (as of 08 Aug 2023)
What this means for you
Registered since 08 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79344278
- Registration number
- 7129071
- Mark type
- Stylized text
- Filed
- 13 Apr 2022
- Published for opposition
- 23 May 2023
- Registered
- 08 Aug 2023
- Attorney of record
- Mark H. Tidman
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use
- Class 005 — Pharmaceuticals: Diagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases
- Class 042 — Scientific and technological services: Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic activity; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of enzymatic activity
- Class 044 — Medical, beauty and agricultural services: Medical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons
Owner
Prosecution history
- 21 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 03 Dec 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Nov 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Nov 2023 — FINAL DISPOSITION PROCESSED
- 08 Nov 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 08 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 24 May 2023 — NOTIFICATION PROCESSED BY IB
- 23 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 May 2023 — PUBLISHED FOR OPPOSITION
- 03 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 May 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 03 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Apr 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Apr 2023 — REFUSAL PROCESSED BY IB